15 results
COVID-19 Infection - Clinical Presentation and Disease Progression for Severe Cases

Via https://doi.org/10.1007/s00134-020-05967-x

#COVID19 #Hospitalization #Disease #Progression #Severe
COVID-19 Infection ... Presentation and Disease ... 020-05967-x #COVID19 ... Progression #Severe #Coronavirus ... #Diagnosis #Management
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Factors for Severe Disease ... Laboratory Workup COVID ... #criticalcare #Guidelines ... NonIntensivist #diagnosis #management
Multi-System Inflammatory Syndrome in Children (MIS-C) vs. Kawasaki Disease
CDC Case Definition for MIS-C;
 • < 21
Kawasaki Disease ... • Positive COVID ... Comparison #diagnosis #peds ... #pediatrics #COVID19 ... #Coronavirus #MultiSystem
CALMER: A Talking Map for COVID-Related Proactive Planning
 Check in 
 Ask about COVID
 Lay out
Talking Map for COVID-Related ... in Ask about COVID ... Allocation Show the guideline ... Resource #Allocation #Management ... #Coronavirus
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
• Infection: Coronavirus ... Disease 2019 a.k.a ... -2, 2019 Novel Coronavirus ... Cheatsheet #Diagnosis #Management ... Summary #SARSCoV2 #Coronavirus
Acute-on-Chronic Liver Failure (ACLF) Clinical Guidelines

ACLF = possibly reversible condition in those with CLD (± cirrhosis)
ACLF) Clinical Guidelines ... underlying liver disease ... Hepatitis Procedures Management ... Cirrhosis #Hepatology #gastroenterology ... #management #diagnosis
CDC Risk Classification for Asymptomatic Healthcare Personnel Following Exposure to Patients with Coronavirus Disease (COVID-19) or
Patients with Coronavirus ... Disease (COVID- ... Classification #COVID19 ... #Restrictions #Management
Therapeutic Management of Adults Hospitalized for COVID-19 Based on Disease Severity
Antiviral, Immunomodulator and Anticoagulation Recommendations by
Therapeutic Management ... -19 Based on Disease ... Recommendations by Disease ... #Management #anticoagulation ... treatment #NIH #Guidelines
Bamlanivimab EUA - High Risk Criteria
 • BMI ≥ 35
 • Chronic kidney disease
 • Diabetes
Chronic kidney disease ... Immunosuppressive disease ... Cardiovascular disease ... EUA #Criteria #covid19 ... #coronavirus #management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Valvular heart disease ... Congenital heart disease ... Hypertensive heart disease ... e.g., <50%), ESC guidelines ... teratogenic GDMT meds